Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
+$254M |
| 2 |
Cadence Bank
CADE
|
+$211M |
| 3 |
Realty Income
O
|
+$152M |
| 4 |
Verizon
VZ
|
+$148M |
| 5 |
Amazon
AMZN
|
+$130M |
Top Sells
| 1 |
KSU
Kansas City Southern
KSU
|
+$347M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
+$330M |
| 3 |
UFS
DOMTAR CORPORATION (New)
UFS
|
+$197M |
| 4 |
Oracle
ORCL
|
+$166M |
| 5 |
Federal Realty Investment Trust
FRT
|
+$148M |
Sector Composition
| 1 | Technology | 17.41% |
| 2 | Financials | 17.04% |
| 3 | Industrials | 12.56% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Dianthus Therapeutics
DNTH
$1.22B
| $797K | ﹤0.01% |
11,238
-740
| -6% | -$52.5K |
|
3077
Oak Valley Bancorp
OVLY
$242M
| $791K | ﹤0.01% |
45,452
| – | – |
|
|
SVT
3078
DELISTED
Servotronics
SVT
| $787K | ﹤0.01% |
62,051
-3,662
| -6% | -$46.4K |
|
3079
Mizuho Financial
MFG
$83.4B
| $780K | ﹤0.01% |
305,968
+26,907
| +10% | +$68.6K |
|
3080
Sprout Social
SPT
$816M
| $775K | ﹤0.01% |
8,547
+107
| +1% | +$9.7K |
|
3081
Maravai LifeSciences
MRVI
$376M
| $774K | ﹤0.01% |
18,461
+771
| +4% | +$32.3K |
|
|
SGMA
3082
DELISTED
Sigmatron International
SGMA
| $770K | ﹤0.01% |
74,519
+17,820
| +31% | +$184K |
|
3083
Sonida Senior Living
SNDA
$492M
| $768K | ﹤0.01% |
26,954
+12,995
| +93% | +$370K |
|
|
ZEPP
3084
Zepp Health
ZEPP
$744M
| $767K | ﹤0.01% |
37,956
+10,311
| +37% | +$208K |
|
|
RDIB
3085
Reading International Class B
RDIB
$266M
| $759K | ﹤0.01% |
33,002
-1,842
| -5% | -$42.4K |
|
3086
First Capital
FCAP
$145M
| $756K | ﹤0.01% |
18,917
+445
| +2% | +$17.8K |
|
|
VXRT
3087
DELISTED
Vaxart
VXRT
| $751K | ﹤0.01% |
+119,788
| New | +$751K |
|
3088
Canterbury Park Holding Corp
CPHC
$84.8M
| $746K | ﹤0.01% |
43,225
| – | – |
|
3089
Gogo Inc
GOGO
$1.36B
| $744K | ﹤0.01% |
+54,994
| New | +$744K |
|
3090
MEI Pharma
MEIP
$101M
| $742K | ﹤0.01% |
13,899
-4,040
| -23% | -$216K |
|
|
LCI
3091
DELISTED
Lannett Company, Inc.
LCI
| $736K | ﹤0.01% |
113,627
-102,654
| -47% | -$665K |
|
|
ALPN
3092
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $735K | ﹤0.01% |
53,064
+2,700
| +5% | +$37.4K |
|
|
SCU
3093
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $720K | ﹤0.01% |
+33,707
| New | +$720K |
|
3094
Altimmune
ALT
$324M
| $719K | ﹤0.01% |
+78,470
| New | +$719K |
|
|
VIOT
3095
Viomi Technology
VIOT
$226M
| $718K | ﹤0.01% |
296,810
+50,055
| +20% | +$121K |
|
3096
Global Water Resources
GWRS
$266M
| $717K | ﹤0.01% |
41,938
+11,992
| +40% | +$205K |
|
|
FNHC
3097
DELISTED
FedNat Holding Company Common Stock
FNHC
| $715K | ﹤0.01% |
507,361
-111,057
| -18% | -$157K |
|
3098
Kinetik
KNTK
$2.58B
| $714K | ﹤0.01% |
23,296
+5,396
| +30% | +$165K |
|
|
SIOX
3099
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $713K | ﹤0.01% |
552,734
+161,102
| +41% | +$208K |
|
3100
Hennessy Advisors
HNNA
$91.7M
| $711K | ﹤0.01% |
65,503
+2
| +0% | +$22 |
|